RAP 0.00% 20.5¢ resapp health limited

From the July 1 announcement...“Demonstrating the accuracy of...

  1. 1,203 Posts.
    lightbulb Created with Sketch. 30
    From the July 1 announcement...



    “Demonstrating the accuracy of our OSA detection algorithms in the home setting will be an
    important milestone in the development of a highly-scalable, accurate and easy-to-use screening
    test for OSA,” said Tony Keating, CEO and Managing Director of ResApp. “Screening of OSA today
    relies mostly on questionnaire-based screening tools, which in a study recently published in the
    Medical Journal of Australia were found to have a sensitivity as low as 36-51%, meaning that a
    large portion of people with clinically relevant OSA are missed. This highlights the need for a more
    accurate screening tool. The recent inclusion of these screening questionnaires into the
    requirements for Medicare reimbursement of sleep testing has impacted recruitment, however
    we are now close to finalising recruitment and are looking forward to releasing results from the
    study during the third quarter.”


    OSA completed study next?
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.